STIGMA, DISCRIMINATION AND ASSOCIATED DETERMINANTS AMONG PEOPLE LIVING WITH HIV/AIDS ACCESSING ANTI-RETROVIRAL THERAPY IN IKEJA, LAGOS STATE, NIGERIA.
Gambo Sidi Ali 1
Abraham Oloture Ogwuche 2
Alexander Idu Entonu 2✉ Email
Adekunle Kabir Durowade 3
1
A
A
Department of Public Health, College of medicine Ahmadu Bello University Zaria
2 Department of Medicine and Surgery University of Ilorin Ilorin Nigeria
3
A
Department of Community Medicine Afe Babalola University Ado-Ekiti
Gambo Sidi Ali1, Abraham Oloture Ogwuche2, Alexander Idu Entonu2 Adekunle Kabir Durowade3
Affiliations
1 Department of Public Health, College of medicine, Ahmadu Bello University Zaria.
2 Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria
3 Department of Community Medicine, Afe Babalola University Ado-Ekiti
Alexander Entonu
alexanderentonu60@gmail.com
Department of medicine and surgery, university of Ilorin, Ilorin, Nigeria.
Corresponding author
ABSTRACT
Discrimination and stigma towards those living with HIV/AIDS (PLWHAs) pose serious obstacles to their ability to manage their disease and achieve overall wellbeing. These obstacles make it difficult to receive mental health assistance, prolong social isolation, and impede access to healthcare resources. The purpose of this study is to look into the types, prevalence, and factors that influence stigma and prejudice that PLWHAs in Ikeja, Lagos State, Nigeria, face when they seek antiretroviral therapy (ART). The study also aims to comprehend the ways in which these experiences impact PLWHAs' mental health and ability to receive healthcare.
Structured questionnaires were used in this cross-sectional study to gather data from 400 PLWHAs in Ikeja who were undergoing ART. Aspects of stigma such as negative self-image, disclosure concerns, personalized stigma, and public attitudes were all included in the questionnaire. The data were summarized using descriptive statistics, and significant predictors of discrimination and stigma were found using logistic regression analysis. The study also looked at how stigma affects mental health and healthcare access, with an emphasis on identifying important socio-demographic variables that influence these outcomes.
The results showed high prevalence of stigma against PLWHAs in Ikeja, in particular, 37.75% of respondents reported they have encountered stigma associated to HIV while seeking healthcare services, and 89.75% of respondents said they were aware of this stigma. Furthermore, 52% of respondents agreed that stigma is exacerbated by the media and societal views, and 45.5% thought that cultural and religious beliefs affected how PLWHAs were treated in their society. Gender, socioeconomic class, and educational attainment were found to be significant predictors of stigma.
In addition, 41.5% of respondents experienced unfavorable views from family or friends, and 48.75% of respondents felt ashamed or condemned due to their HIV status. Similarly, 64.25% of PLWHAs said stigma had a major negative impact on their social interactions and mental health, and 65% said stigma made them decide not to disclose their HIV status. While more than a third, 39.75%, of the respondents said that stigma made it difficult for them to get ART and other essential medical services, two-thirds, 67%, stated that the attitudes of healthcare providers influenced their desire to ask for assistance.
The study found widespread stigma and prejudice against PLWHAs with a negative influence on mental health and access to healthcare. The study suggests strengthening anti-discrimination laws, holding frequent training sessions for healthcare professionals, improving education and awareness campaigns, and increasing support services for PLWHAs in order to solve these problems. Stakeholders can improve the inclusive and supportive environment for people living with HIV/AIDS by putting these focused actions into practice, which will eventually improve health outcomes and quality of life. These initiatives are essential for reducing HIV/AIDS stigma and advancing a more equitable and compassionate society.
Key words:
Stigma
Discrimination
People living with HIV/AIDs
A
A
A
A
A
INTRODUCTION
HIV/AIDS stands as a persistent and severe health condition with widespread implications for global public health. 1,2 recognized by the World Health Organization (WHO) as a worldwide public health emergency, HIV continues to pose significant challenges, marking over three decades since its emergence. This pandemic has inflicted devastating consequences, claiming the lives of millions globally and causing severe harm to countless others. The virus has affected over 75 million people since its onset .1 In the year 2022 alone, 39 million individuals were living with HIV, and 1.3 million succumbed to AIDS-related causes worldwide. 1
The impact of HIV/AIDS remains particularly pronounced in the Sub-Saharan region which continues to bear the brunt of the global HIV/AIDS burden, representing two-thirds of the total cases worldwide.3 HIV which stands for human immunodeficiency virus leads to the disease AIDS (acquired immuno- deficiency syndrome), if left untreated.4 Presently, there are 25 million adults and children living with the virus in this region, constituting nearly 70% of the global figure. The statistics reveal an alarming scenario with approximately 1.9 million new HIV infections and 1.2 million AIDS-related deaths reported in Sub-Saharan Africa 5. Nigeria, within this context, shoulders a significant portion of the epidemic, hosting an estimated 3.2 million individuals living with HIV, positioning the country among those with the highest HIV burden globally, second only to South Africa. In 2005, the international community embraced the goal of universal access to HIV prevention, treatment, care and support by 2010.6,7 National HIV/AIDS programs must fortify their health systems and remove any obstacles to treatment and preventive initiatives in order to meet this objective. Nigeria has implemented several measures to stop the spread of disease.8 People living with HIV/AIDS (PLWHAs) who have taken an HIV test and are on antiretroviral therapy (ART) have increased significantly as a result of international initiatives like the US Presidential Emergency Plan for AIDS Relief (PEPFAR) program. 9 In addition, there are many more antenatal women with HIV positivity who have received ART to prevent mother to child transmission of HIV.10 The challenges many of these global and national programs face in a multi-diverse socio-cultural society like Nigeria are the problems of stigma and discrimination(S&D).1114 The issues of S&D described by Jonathan Man 15 as the third phase of the HIV pandemic poses a serious threat to prevention and treatment. Therefore, for Nigeria to achieve her national policy on HIV/AIDS, aimed at controlling the spread of the infection and its impact, the issue of S&D needs to be addressed.8,16 Significant research and knowledge on HIV related S&D in many ethnic and cultural settings that constitute Nigeria, are important tool in understanding this “hidden factors” that are impediments to effective prevention and treatment. Incorporating these findings into national prevention strategies will go a long way in reducing the transmission of the virus in the population.17
In 2017, the demand for Anti-Retroviral Therapy (ART) in Nigeria was 1.9 million, with over 52% of those affected receiving treatment. The South-South region had the highest HIV prevalence at 3.1%, while Lagos state recorded 1.4%. Global efforts to curb HIV have significantly reduced infection rates, especially in developed countries, by extending the lives of those infected. Though no cure exists, Highly Active Anti-Retroviral Therapy (HAART) has transformed HIV from a terminal illness to a manageable chronic condition. 2224
A
Over the past decade, Nigeria has witnessed notable advancements in curbing the HIV/AIDS epidemic.25,26 The 2019 National AIDS and Reproductive Health Survey (NARHS) demonstrated a substantial reduction in the national HIV prevalence, decreasing from a peak of 5.8% in 2001 to 3.1%.27 This accomplishment is largely attributed to impactful interventions such as Behavior Change Programs, HIV care and support initiatives, Prevention of Mother to Child Transmission (PMTCT), and the implementation of Highly Active Anti-Retroviral Therapy (HAART).19 HAART treatment primarily aims to reduce the viral load to undetectable levels, fostering immune reconstitution and notable clinical improvement. Additionally, HAART has proven effective in preventing opportunistic infections.2830 Successful outcomes in the management of HIV/AIDS hinge significantly on adherence to HAART, as underscored by studies such as Shah (2007) and Giri et al. (2013).
The reported adherence rates to ART medication among people living with HIV (PLHIV) in Nigeria vary from 44–98%.11,31,32 Factors shown to be associated with good adherence include text message as reminders, patient selected treatment partners, use of pill box, age and gender. On the other hand, psychiatric morbidity negatively had adverse impacts on adherence.11 Despite this efforts, HIV/AIDS stigma continue to re-emerge as a formidable threat, particularly among many Nigerians who lack awareness of the realities surrounding HIV and AIDS, leading to avoidance and stigmatization of individuals affected by the virus due to misconceptions about its transmission. This misguided belief suggests that one can contract the virus through association or close contact with an infected person.33 S&D as described by various sources, represent social barriers that significantly impact the life experiences of individuals. The stigma associated with HIV and AIDS tends to marginalize people within their communities, adversely affecting the overall quality of life for PLHIV. Stigma is often synonymous with social disgrace. Research indicates that individuals reporting high levels of stigma are more than four times likely to experience limited access to healthcare. Moreover, HIV and AIDS-related stigma can give rise to discrimination, such as restrictions on travel, healthcare facility usage, employment opportunities, and social interactions for PLHIV.13,34, 60
Although there have been few studies as regard stigma and discrimination against individuals living with HIV/AIDS,35–58 it remains prevalent, impacting their access to care and quality of life. This research aims to comprehensively explore the knowledge, prevalence, types and determinants of stigma and discrimination among people accessing Anti-retroviral Therapy (ART) in Ikeja, Lagos State, Nigeria.
This research aims to fill a gap in the literature by exploring the relationship between stigma, discrimination, and factors affecting access to anti-retroviral therapy (ART) for people living with HIV/AIDS (PLWHA) in Ikeja, Lagos State, Nigeria. The geographical scope is limited to Ikeja, a prominent urban area, allowing for an in-depth exploration within a defined locale. It seeks to provide practical insights for the local healthcare sector, identifying cultural, socioeconomic, and healthcare-related influences that impact PLWHA's well-being. The findings could guide policymakers and healthcare professionals in developing inclusive interventions to reduce stigma and improve healthcare practices. Additionally, the study aims to empower both PLWHA and the wider community by increasing public understanding and contributing to global efforts against HIV-related discrimination.
METHODOLOGY
This study that was conducted in Lagos State in January 2024, focused on Ikeja, a major economic and healthcare hub. Despite being the smallest state by landmass, Lagos had a population of 12.7 million in 2019, with Ikeja being home to over 470,200 people.35, 61 Overcrowding, rural-urban migration, and low-income earners characterize the state. Ikeja’s diverse urban-suburban population and its healthcare infrastructure, including several busy Anti-Retroviral Therapy (ART) clinics, provide an ideal backdrop to examine stigma and discrimination among people living with HIV/AIDS (PLWHA). The study aims to highlight the socio-economic and healthcare challenges affecting access to ART services in this region.
A crosssectional hospitalbased study conducted at the Antiretroviral Therapy Centre (ATC) was employed. Among all adult clients on ART regimen, accessing treatment at any HAART clinic in Ikeja, Lagos state.
Inclusion criteria
A
Adult HIV patients 18 years and above
Patients with confirmed HIV-positive status who had received Anti-Retroviral drugs for
at least 1 week prior to the study. This was to allow only established HAART clinic users in the study.
Individuals accessing Anti-retroviral Therapy (ART) services in any HAART clinic within Ikeja, Lagos state.
Exclusion criteria
Pregnant women
Terminally ill/debilitated patients
Patients on admission
A sample size of 400 was selected using the fischer formula. A simple random sampling technique was used. Out of seven known ART centers, three hospitals were selected using simple random sampling. The names of all seven centers were written on separate slips of paper, placed in a container, and three slips were drawn randomly to select Lagos State University Teaching Hospital Ikeja, 661 Nigerian Air Force Hospital Ikeja, and Primary Health Centre Ogba. For patient selection, a list of all PLWHAs undergoing ART at these hospitals was obtained using a random number generator, 400 patients were chosen from these lists to participate in the study, ensuring an unbiased and representative sample.
Structured questionnaires was administered to individuals accessing ART in Ikeja to gather quantitative data on their experiences of stigma, discrimination, and related factors. These instruments include validated scales or items measuring stigma levels, discrimination experiences, and healthcare access barriers. The sociodemographic details of the participants was recorded using a pretested questionnaire schedule. Social stigma related to HIV was assessed using the Berger HIV Stigma Scale. During the process of patient interaction, queries/questions regarding HIV/AIDS/ART was clarified and solved. Any additional openended responses of the subjects was noted, without further probing.
The Berger Stigma Scale measures HIV-related stigma across four domains: Personalized Stigma, Disclosure Concerns, Negative Self Image, and Public Attitudes, totaling 40 items. Scores range from 40 to 160, with higher scores indicating greater stigma.62,63 The scale has strong reliability (coefficients 0.90–0.96) and takes 15–25 minutes to complete. Knowledge of HIV was assessed through a separate scoring system, with scores over 60% classified as good knowledge.
A
Ethical clearance was obtained from the Lagos state university teaching hospital Health Research and Ethics Committee with the Ref.No LREC/06/10/2499, and informed consent was obtained from participants. Participants were informed of their right to withdraw from the study at any time without penalty. Research assistants were trained to ensure confidentiality, and no personal identifiers were included in the data to prevent stigma.
Data was analyzed using STATA version 11.0, with statistical tests like Chi-squared, t-statistic, and logistic regression. A p-value of < 0.05 was considered significant. Univariate analysis presented frequencies, percentages, means, and standard deviations. Knowledge scores were graded, and associations between stigma, discrimination, and ART accessibility were tested using Chi-square and logistic regression, with significance set at p < 0.05.
RESULT
A total of 409 questionnaires were given out and 400 returned indicating a 98% response rate. Univariate analysis is expressed as frequency tables, mean and standard deviation while bivariate and multivariate was presented in tables.
The first section of the finding’s presentation covered the respondents' demographic and socioeconomic details.
Table 1
Demographic characteristics of respondents. N = 400
Variable
Frequency
Percentage (%)
Age (in years)
   
< 20
6
1.5
20–29
105
26.3
30–39
110
27.5
40–49
107
26.7
≥ 50
72
18.0
Mean Age ± SD
39 ± 11
 
Gender
   
Female
201
50.3
Male
199
49.7
Marital status
   
Single
147
36.8
Married
195
48.8
Separated/Divorced
31
7.7
Widowed
27
6.7
Ethnicity
   
Yoruba
120
30.0
Hausa
43
10.7
Igbo
121
30.3
Others
116
29.0
Religion
   
Christianity
308
77.0
Islam
92
23.0
Education status
   
None
8
2.0
Primary
11
2.8
Secondary
87
21.7
Tertiary
294
73.5
Occupation
   
Civil servant
136
34.0
Artificer
20
5.0
Trader
168
42.0
Student
28
7.0
Others
48
12.0
Average monthly income (₦)
   
< 50,000
113
28.3
50,000-100,000
71
17.7
100,001-500,000
119
29.7
> 500,000
97
24.3
Average monthly income ± SD
301568.1 ± 318389.2
 
HIV status Disclosure
   
Undisclosed
215
53.7
Disclosed
185
46.3
Partner’s HIV status
   
Positive
171
42.8
Negative
110
27.5
Unknown
119
29.7
Duration on ART
   
< 5
211
52.7
≥ 5
189
47.3
Mean duration on ART ± SD (in years)
5.3 ± 5
 
Area of Residence
   
Within Ikeja
148
37.0
Outside Ikeja LGA
173
43.3
Outside Lagos State
79
19.7
From Table 1, more than a quarter of respondents were in the 20-29years (26.3%), 30-39years (27.5%), and 40-49years (26.7%) with a mean of 39 ± 11. Gender distribution shows a near-equal split with 50.3% female and 49.7% male. As regards the level of education, more than two thirds of participants (73.5%) have completed university education, with 2.0% having no formal education. The average monthly income of the participants varies; smaller proportion earn between ₦50,000 and ₦100,000 (17.7%), while the bulk earn between ₦100,000 and ₦500,000 (29.7%). The monthly average income is roughly ₦301,568 ± ₦318,389.
Concerning HIV status disclosure, more than one third of participants (46.3%) have declared their status, compared to over half (53.75%) who have not. For partners' HIV status more than one third (42.75%) of the participants reported having an HIV-positive spouse. With a mean of 5.3 ± 5 years, the participants' length of time on ART reveals more than half of participants (52.7%) have been on therapy for less than five years.
Awareness and Knowledge of Stigma and Discrimination
Table 2
Assessment of level of awareness and knowledge regarding stigma and discrimination. N = 400
Variable
Yes (%)
Are you aware of what stigma related to HIV/AIDS means?
359(89.7)
Have you received information regarding discrimination against PLWHAs?
232(58.0)
Do you know about support services available to address stigma and discrimination faced by PLWHAs?
187(46.7)
Have you participated in educational programs related to HIV/AIDS stigma and discrimination?
184(46.0)
Are you aware that reducing stigma could improve healthcare access for PLWHAs?
317(79.3)
Knowledge
 
Good
160(40.0)
Poor
240(60.0)
Table 2: Among the respondents, 89.7% were aware of what stigma related to HIV/AIDS means, indicating high awareness levels. However, only 46.7% knew about support services available to address stigma and discrimination faced by PLWHAs. Additionally, 58.0% had received information regarding discrimination against PLWHAs, and 46.0% had participated in educational programs related to HIV/AIDS stigma and discrimination. Furthermore, 79.3% were aware that reducing stigma could improve healthcare access for PLWHAs. Despite high awareness, more than half (60.0%) of respondents had poor knowledge overall.
Prevalence of Stigma and Discrimination
Table 3
Determination of level of prevalence of stigma and discrimination encountered by respondents. N = 400
Variable
Yes
Have you ever been treated differently by healthcare providers due to your HIV status?
155(38.7)
Have you encountered negative attitudes or behaviors from family or friends because of your HIV status?
166(41.5)
Have you ever felt ashamed or judged because of your HIV status?
195(48.7)
Do you believe there is widespread discrimination against PLWHAs in Ikeja?
192(48.0)
A
Have you personally experienced verbal abuse or insults related to your HIV status?
127(31.7)
Prevalence
 
High
81(20.3)
Low
319(79.7)
From Table 3 above, more than a third of participants (38.7%) reported being treated differently by healthcare providers due to their HIV status. Negative attitudes or behaviors from family or friends were encountered by 41.5% of participants, 48.7% felt ashamed or judged because of their HIV status, and 48.0% believed there is widespread discrimination against PLWHAs in Ikeja.
A
Personal experiences of verbal abuse or insults related to HIV status were reported by less than a third (31.7%) of respondents.
The prevalence of stigma and discrimination was generally low, with more than two third (79.7%) of respondents classified as experiencing low prevalence. This classification was based on scoring and grouping responses into low and high prevalence categories.
Forms of Stigma and Discrimination
Table 4
shows the different forms of stigma and discrimination experienced by respondents. N = 400
Variable
Yes (%)
Have you experienced stigma while accessing healthcare services for HIV/AIDS
151(37.7)
Have you encountered discrimination in educational or workplace settings due to
119(29.7)
Do you perceive media or societal attitudes contribute to stigma associated with HIV/AIDS
208(52.0)
Do religious or cultural beliefs influence the treatment of PLWHAs in your community
182(45.5)
Have you witnessed/experience instances where PLWHAs were excluded from community
129(32.3)
Do you believe poverty or socioeconomic status influences how PLWHAs are treated
224(56.0)
Have you experienced stigma or discrimination due to gender or sexual orientation
164(41.0)
Do healthcare provider attitudes affect stigma faced by PLWHAs
235(58.7)
Do you think education level or awareness impacts how people treat PLWHAs in Ikeja
278(69.5)
Are political or governmental policies contributing to discrimination against PLWHAs
209(52.3)
Do you perceive the community in Ikeja to hold negative attitudes towards PLWHAs
174(43.5)
Have you observed community-based programs aimed at reducing stigma against PLWHAs
174(43.5)
Do you believe media representations of HIV/AIDS contribute to negative perception
224(56.0)
Do you think healthcare provider attitudes affect PLWHAs' willingness to seek help
268(67.0)
Do PLWHAs in Ikeja face challenges accessing ART and necessary healthcare service
159(39.7)
Have you or others encountered barriers/difficulties accessing healthcare due to your HIV status?
163(40.7)
Are PLWHAs in Ikeja comfortable disclosing their HIV status to others?
89(22.3)
Does fear of stigma or discrimination influence the decision to disclose HIV status?
260(65.0)
Have you observed changes in your mental health or self-esteem because of your HIV status?
219(54.7)
Do you believe stigma significantly affects the mental well-being and social interactions of PLHVAs?
257(64.3)
Do you think poverty amplifies the stigma experienced by PLWHAs in Ikeja?
248(62.0)
Have you or others encountered barriers/difficulties accessing healthcare due to HIV/AIDS-related stigma?
163(40.7)
Does fear of stigma or discrimination influence the decision to disclose HIV status?
260(65.0)
Have you observed changes in your mental health or self-esteem because of your HIV status?
219(54.7)
Do you believe stigma significantly affects the mental well-being and social interactions of PLWHAs?
257(64.3)
Do you think poverty amplifies the stigma experienced by PLWHAs in Ikeja?
248(62.0)
Have you noticed differences in the treatment of PLWHAs based on socioeconomic status?
196(49.0)
Can education and awareness programs substantially reduce stigma and discrimination related to HIV/AIDS?
283(70.7)
Have educational campaigns in Ikeja shown any impact on reducing stigma against PLWHAs?
232(58.0)
Have been gossiped about
96(24.0)
Verbally insulted/harassed or threatened
82(20.5)
Husband, spouse, or other household members have been discriminated against
75(18.7)
Sexual rejection
125(31.3)
Excluded from social gatherings
61(15.3)
Excluded from family activities
65(16.3)
Discriminated against by other PLWHAs
52(13.0)
Excluded from religious activities
42(10.5)
From Table 4, two third (67.0%) of respondents believe that healthcare provider attitudes affect PLWHAs' willingness to seek help, highlighting a crucial factor in stigma and discrimination, 69.5% think that education and awareness impact how people treat PLWHAs in Ikeja. The perception that poverty or socioeconomic status influences the treatment of PLWHAs is shared by more than half (56.0%) of respondents, while the fear of stigma or discrimination affecting the decision to disclose HIV status was noted by 65.0% of participants. Furthermore, about two third (64.3%) of participants believe that stigma significantly impacts the mental well-being and social interactions of PLWHAs and 70.7% agree that education and awareness programs can substantially reduce stigma and discrimination related to HIV/AIDS.
Table 4
5 Subscale of stigma distribution with Gender
Subscale
Mean Score
Male
Female
P (Independent t-test)
Personalized stigma
2.46 ± 2.04
2.29 ± 2.04
2.63 ± 2.02
0.0946
Disclosure concerns
1.43 ± 0.62
1.42 ± 0.60
1.44 ± 0.64
0.7391
Negative self-image
1.68 ± 1.02
1.61 ± 1.07
1.74 ± 0.96
0.1748
Public attitude
6.32 ± 4.43
6.48 ± 4.64
6.15 ± 4.42
0.4760
The table demonstrated the mean scores for the various HIV/AIDS stigma subscales among participants who were male and female, as well as the findings of an independent t-test comparing these scores. 2.46 ± 2.04 was the mean score for personalized stigma. Although the mean score of females was slightly higher (2.63 ± 2.02) than that of males (2.29 ± 2.04), there was no statistically significant difference between the two groups (p = 0.0946).
A
Participants' average score for disclosure concerns was 1.43 ± 0.62. Regarding these issues, there was no discernible difference between the male and female participants (1.42 ± 0.60 and 1.44 ± 0.64, respectively; p = 0.7391).
The mean score for having a poor self-image was 1.68 ± 1.02. The mean score of females was 1.74 ± 0.96, somewhat higher than that of males (1.61 ± 1.07), although this difference was not statistically significant (p = 0.1748). The mean score for public attitude was 6.32 ± 4.43. Regarding public attitude, there was no statistically significant difference between males (6.48 ± 4.64) and females (6.15 ± 4.42) (p = 0.4760).
All things considered, these findings imply that there were no appreciable gender disparities in the participants' mean scores for personalized stigma, disclosure worries, negative self-image, or public opinion.
Interpretation of Stigma Subscale Correlations
Table 4
6 Correlation between the different subscales of stigma.
Stigma subscale
Personalized stigma
Disclosure concerns
Negative self-image
Public attitude
Personalized stigma
1
     
Disclosure concerns
0.0296
1
   
Negative self-image
0.5838
0.1195
1
 
Public attitude
0.8012
0.0554
0.4698
1
The data reveals significant relationships between stigma subscales in the study. There is a moderate positive correlation between personalized stigma and negative self-image at 0.5838, indicating that higher levels of personalized stigma are associated with more negative self-perceptions. A strong positive correlation of 0.8012 exists between personalized stigma and public attitude, suggesting that personal stigma is closely linked to perceptions of societal attitudes. Disclosure concerns show a weak positive correlation with personalized stigma at 0.0296, and a weak positive correlation with negative self-image at 0.1195. The strongest correlation is between personalized stigma and public attitude. Meanwhile, public attitude and negative self-image have a moderate positive correlation of 0.4698, while disclosure concerns and public attitude show a weak correlation of 0.0554.
Section E: Factors contributing to Experience of Stigma and Discrimination
Table 4
7 Association of socio-demographic parameters of study participant and stigmatization
Variable
Stigmatization
χ²
P value
 
High (%)
Low (%)
Total (100%)
   
Age
         
< 20
2(33.3)
4(66.7)
6
   
20–29
34(32.4)
71(67.6)
105
   
30–39
47(42.7)
63(57.3)
110
3.33
0.504
40–49
35(32.7)
72(67.3)
107
   
>=50
25(34.7)
47(65.3)
72
   
Average monthly income (#)
         
< 50,000
105(92.9)
8(7.1)
113
   
50,000-100,000
38(53.5)
33(46.5)
71
290.74
< 0.001
100,001-500,000
0(0.0)
119(100.0)
119
   
> 500,000
0(0.0)
97(100.0)
97
   
Gender
         
Male
77(38.7)
122(61.3)
199
1.49
0.222
Female
66(32.8)
135(67.2)
201
   
Marital Status
         
Single
55(37.4)
92(62.6)
147
   
Married
70(35.9)
125(64.1)
195
   
Separated/Divorced
10(32.3)
21(67.7)
31
0.78
0.853
Widowed
8(29.6)
19(70.4)
27
   
Partner’s HIV status
         
Positive
74(43.3)
97(56.7)
171
   
Negative
30(27.3)
80(72.7)
110
8.12
0.017
Unknown
39(32.8)
80(67.2)
119
   
Ethnicity
         
Yoruba
45(37.5)
75(62.5)
120
   
Hausa
14(32.6)
29(67.4)
43
0.97
0.808
Igbo
40(33.1)
81(66.9)
121
   
Others
44(37.9)
72(62.1)
116
   
Religion
         
Christianity
106(34.4)
202(65.6)
308
1.04
0.308
Islam
37(40.2)
55(59.8)
92
   
Educational status
         
None
3(37.5)
5(62.5)
8
   
Primary
4(36.4)
7(63.6)
11
6.57
0.087
Secondary
21(24.1)
66(75.9)
87
   
Tertiary
115(39.1)
179(60.9)
294
   
HIV status disclosure
         
Undisclosed
76(35.4)
139(64.6)
215
   
Disclosed
67(36.2)
118(63.8)
185
0.03
0.857
Occupation
         
Civil servant
57(41.9)
79(58.1)
136
   
Artificer
5(25.0)
15(75.0)
20
   
Trader
54(32.1)
114(67.9)
168
4.21
0.379
Student
10(35.7)
18(64.3)
28
   
Others
17(35.4)
31(64.6)
48
   
Area of Residence
         
Within Ikeja LGA
51(34.5)
97(65.5)
148
   
Outside Ikeja LGA
58(33.5)
115(66.5)
173
2.31
0.316
Outside Lagos State
34(43.0)
45(57.0)
79
   
Duration on ART (in years)
         
< 5
75(35.6)
136(64.4)
211
0.01
0.928
≥ 5
68(36.0)
121(64.0)
189
   
The partner's HIV status was found to be a significant variable in the stigmatization analysis. With p = 0.017 and χ² = 8.12, there was clear statistical significance. This implies that a person's ability to avoid stigmatization is significantly influenced by the HIV status of their partners.
Additionally, there was an association between respondents' average monthly income and stigmatization (χ² = 290.74, p < 0.001, indicating that socioeconomic position is a key factor influencing stigmatization.
However, a number of factors had no statistically significant association with stigmatization. The χ² = 3.33 and the p = 0.504 for age did not indicate an association.
The following factors did not significantly differ (p > 0.050): gender, marital status, ethnicity, religion, educational status, disclosure of HIV status, occupation, place of residence, and duration on ART.
Table 4
8 Association of socio-demographic parameters of study participants and Discrimination
Variable
Discrimination
χ²
P value
 
High (%)
Low (%)
Total (100%)
   
Age
         
< 20
0(0.0)
6(100.0)
6
   
20–29
9(8.6)
96(91.4)
105
   
30–39
12(10.9)
98(89.1)
110
1.50
0.826
40–49
12(11.2)
95(88.8)
107
   
≥ 50
9(12.5)
63(87.5)
72
   
Average monthly income (#)
         
< 50,000
20(17.7)
93(82.3)
113
   
50,000-100,000
16(22.5)
55(77.5)
71
33.06
< 0.001
100,001-500,000
0(0.0)
119(100.0)
119
   
> 500,000
6(6.2)
91(93.8)
97
   
Gender
         
Male
18(9.0)
181(91.0)
199
0.89
0.345
Female
24(11.9)
177(88.1)
201
   
Marital Status
         
Single
12(8.2)
135(91.8)
147
   
Married
23(11.8)
172(88.2)
195
2.52
0.471
Separated/Divorced
5(16.1)
26(83.9)
31
   
Widowed
2(7.4)
25(92.6)
27
   
Partner’s HIV status
         
Positive
31(18.1)
140(81.9)
171
   
Negative
4(3.6)
106(96.4)
110
18.80
< 0.001
Unknown
7(5.9)
112(94.1)
119
   
Ethnicity
         
Yoruba
17(14.2)
103(85.8)
120
   
Hausa
4(9.3)
39(90.7)
43
3.79
0.285
Igbo
8(6.6)
113(93.4)
121
   
Others
13(11.2)
103(88.8)
116
   
Religion
         
Christianity
28(9.1)
280(90.9)
308
2.83
0.093
Islam
14(15.2)
78(84.8)
92
   
Educational status
         
None
2(25.0)
6(75.0)
8
   
Primary
0(0.0)
11(100.0)
11
   
Secondary
9(10.3)
78(89.7)
87
3.08
0.379
Tertiary
31(10.5)
263(89.5)
294
   
Table 4
8 continued
Variable
Discrimination
χ²
P value
 
High (%)
Low (%)
Total (100%)
   
Status disclosure
         
Undisclosed
16(7.4)
199(92.6)
215
   
Disclosed
26(14.1)
159(85.9)
185
4.63
0.031
Occupation
         
Civil servant
18(13.2)
118(86.8)
136
   
Artificer
6(30.0)
14(70.0)
20
   
Trader
13(7.7)
155(92.3)
168
13.82
0.008
Student
0(0.0)
28(100.0)
28
   
Others
5(10.4)
43(89.6)
48
   
Area of Residence
         
Within Ikeja LGA
21(14.2)
127(85.8)
148
   
Outside Ikeja LGA
11(6.4)
162(93.6)
173
5.69
0.058
Outside Lagos State
10(12.7)
69(87.3)
79
   
Duration on ART
         
< 5
23(10.9)
188(89.1)
211
0.08
0.782
≥ 5
19(10.0)
170(90.0)
189
   
The average monthly income has an association with discrimination among the factors analyzed. With p < 0.001 and χ² = 33.06 there was clear statistical significance. This implies that people's experiences of discrimination are significantly influenced by their financial levels.
The presence of HIV in a partner was also significantly associated with discrimination (χ² = 18.80, p < 0.001). This suggested that a person's ability to avoid discrimination is significantly influenced by their partner's HIV status. Another variable that showed statistical significance in relation to discrimination was status disclosure (χ² = 4.63, p = 0.031). This suggests that a person's chance of facing discrimination is greatly impacted by whether they disclose their HIV status.
It was also found that discrimination was associated with occupation (χ² = 13.8243, p = 0.008) indicating that occupational status has an effect on experiences of discrimination.
However, several factors (including age, marital status, religion, ethnicity, educational attainment, place of residence, and duration on ART) did not show statistically significant differences from one another when it came to discrimination (p value > 0.05).
Table 4
9 Association of sociodemographic parameters of study subjects with Stigmatization (Logistic Regression analysis) N = 400
Variable
Stigmatization
 
OR [95% Conf. Interval]
P > z
Age (years)
   
< 20
Reference
 
20–29
50.41(1.66185–1529.633)
0.024
30–39
44.82(1.607253–1249.628)
0.025
40–49
7.56(0.335789–170.0604)
0.203
> 50
5.92(0.256746–136.8447)
0.267
Gender
   
Female
Reference
 
Male
1.22(0.451968–3.295689)
0.694
Marital Status
   
Single
Reference
 
Married
2.30(0.494824–10.70581)
0.288
Divorced
2.14(0.313285–14.66395)
0.437
Widowed
1.68(0.088629–31.76929)
0.730
Ethnicity
   
Yoruba
Reference
 
Hausa
0.10(0.016882–0.619667)
0.013
Igbo
1.57(0.356462–6.931393)
0.550
Others
1.11(0.310046–3.975394)
0.872
Religion
   
Christianity
Reference
 
Islam
2.34(0.56546–9.66315)
0.241
Educational Status
   
None
Reference
 
Primary
0.06(0.000758–4.869785)
0.21
Secondary
0.28(0.007398–10.97426)
0.500
Tertiary
0.38(0.010955–12.88153)
0.587
Occupation
   
Civil servant
Reference
 
Artificer
0.83(0.024666–28.21668)
0.920
Trader
0.72(0.08047–6.462311)
0.770
Student
0.42(0.123071–1.40783)
0.159
Place of residence
   
Within Ikeja
Reference
 
Outside Ikeja LGA
1.39(0.478736–4.049149)
0.543
Outside Lagos State
4.75(1.085868–20.8087)
0.039
HIV status disclosure
   
Undisclosed
Reference
 
Disclosed
4.37(1.406066–13.56713)
0.011
Table 4
9 continued
Variable
Stigmatization
 
OR [95% Conf. Interval]
P > z
Partner’s Status
   
Positive
Reference
 
Negative
0.61(0.18053–2.091202)
0.436
Unknown
0.70(0.138353–3.495726)
0.659
Years you have been on ART
   
< 5
Reference
 
≥ 5
0.88(0.276574–2.793859)
0.827
Average monthly Income(₦)
   
< 50,000
Reference
 
50,000-100,000
0.03(0.007962–0.110472)
< 0.001
100,001-500,000
   
> 500,000
   
A
Table 4.9 highlights several statistically significant variables associated with stigmatization. Individuals aged 20–29 years have a significantly higher likelihood of experiencing stigmatization with an odds ratio (OR) of 50.41 (95% CI: 1.66–1529.63, P = 0.024), and those aged 30–39 years have an OR of 44.82 (95% CI: 1.61–1249.63, P = 0.025). Ethnicity also plays a role, as Hausa individuals are less likely to experience stigmatization with an OR of 0.10 (95% CI: 0.02–0.62, P = 0.013). Those living outside Lagos State have an increased likelihood of stigmatization, with an OR of 4.75 (95% CI: 1.09–20.81, P = 0.039). Disclosure of HIV status significantly affects stigmatization, with disclosed individuals having an OR of 4.37 (95% CI: 1.41–13.57, P = 0.011). Additionally, individuals with an average monthly income of ₦50,000-₦100,000 are significantly less likely to experience stigmatization, with an OR of 0.03 (95% CI: 0.008–0.11, P < 0.001).
Table 4
10 Association of sociodemographic parameters of study subjects with Discrimination (Logistic Regression analysis) n = 400
Variable
Discrimination
 
OR [95% CI]
P > z
Age
   
> 20
Reference
 
20–29
1.78(0.290562–10.88299)
0.533
30–39
0.70(0.178499–2.752831)
0.611
40–49
0.80(0.249451–2.565658)
0.707
> 50
   
Gender
   
Female
Reference
 
Male
0.33(0.136237–0.789087)
0.013
Marital status
   
single
Reference
 
Married
1.57(0.417577–5.88339)
0.505
Divorced
5.34(0.944528–30.16217)
0.058
Widowed
0.76(0.084505–6.916386)
0.811
Ethnicity
   
Yoruba
Reference
 
Hausa
0.21(0.040554–1.105638)
0.066
Igbo
0.39(0.120352–1.278844)
0.121
Others
0.59(0.213736–1.615236)
0.303
Religion
   
Christianity
Reference
 
Islam
1.59(0.596543–4.232781)
0.354
Level of Educational
   
None
Reference
 
Primary
   
Secondary
0.13(0.013472–1.167885)
0.068
Tertiary
0.12(0.012748–1.041251)
0.054
Occupation
   
Civil servant
Reference
 
Artificer
11.28(2.180583–58.30819)
0.004
Trader
   
Student
0.50(0.201388–1.217385)
0.126
Others
   
Area of residence
   
Within Ikeja
Reference
 
Outside Ikeja
0.35(0.132875–0.904878)
0.030
Outside Lagos
0.76(0.265375–2.194287)
0.616
Status disclosure
   
Undisclosed
Reference
 
Disclosed
1.81(0.750922–4.386543)
0.186
Table 4.10
continued
Variable
Discrimination
 
OR [95% CI]
P > z
Partner’s status
   
Positive
Reference
 
Negative
0.11(0.029828–0.441713)
0.002
Unknown
0.72(0.203469–2.543071)
0.609
Duration on ART
   
< 5 years
Reference
 
>=5 Years
1.57(0.55778–4.428542)
0.392
Average monthly Income(₦)
   
< 50,000
Reference
 
50,000-100,000
1.28(0.516153–3.151279)
0.598
100,001-500,000
   
> 500,000
0.13(0.032582–0.487093)
0.003
Table 4.10 highlights several statistically significant variables associated with discrimination. Males are less likely to experience discrimination with an odds ratio (OR) of 0.33 (95% CI: 0.14–0.79, P = 0.013). Occupation as an artificer significantly increases the likelihood of discrimination, with an OR of 11.28 (95% CI: 2.18–58.31, P = 0.004). Residing outside Ikeja is associated with a decreased likelihood of discrimination, with an OR of 0.35 (95% CI: 0.13–0.90, P = 0.030). Having a partner with a negative HIV status significantly reduces the odds of discrimination, with an OR of 0.11 (95% CI: 0.03–0.44, P = 0.002). Finally, an average monthly income of over 500,000 also significantly lowers the likelihood of experiencing discrimination, with an OR of 0.13 (95% CI: 0.03–0.49, P = 0.003).
DISCUSSION
This study assessed the level of knowledge and HIV-related stigma and discrimination faced by people living with HIV/AIDS in Ikeja local government, Lagos state. The report reveals that majority (89.75%) of participants are aware of the stigma associated with HIV/AIDS, 60% possess only a limited understanding of the issue. This aligns with previous studies showing that although awareness is high, detailed comprehension of stigma and active involvement in educational programs remain low. The high rate of stigma and discrimination against people living with HIV/AIDS (PLWHAs) in Ikeja highlights the complex interactions between institutional operations, cultural norms, and societal views. 61, 62, 64, 65
A significant portion of participants reported experiencing stigma in healthcare settings, which reflects ongoing challenges faced by PLWHAs in accessing healthcare services.66, 67 These findings are consistent with prior research, indicating that negative attitudes from healthcare providers discourage PLWHAs from seeking medical attention, worsening their healthcare outcomes. 57,6870 Discrimination is also widespread in the workplace and educational institutions71, which echoes research demonstrating how HIV stigma infiltrates multiple areas of life, affecting the opportunities and well-being of PLWHAs.73,74
Media portrayals were also cited as contributors to HIV stigma, reinforcing negative stereotypes and societal prejudices. This underscores the role of public perception in perpetuating stigma. Religious and cultural beliefs were identified by many respondents as significant factors influencing attitudes toward PLWHAs. These cultural stigmas pose serious barriers to acceptance and support, further isolating PLWHAs from social and community activities. This social isolation is a recurring theme in HIV stigma studies, as it exacerbates the emotional and psychological toll on affected individuals. 7478
Economic factors were also identified as contributors to stigma. Many participants believed that poverty worsens the stigma associated with HIV, a viewpoint supported by research indicating that PLWHAs with lower socioeconomic status are more vulnerable to discrimination. The report highlights the potential of educational initiatives to reduce stigma, with respondents recognizing that increased awareness and understanding can foster more accepting attitudes and behaviors toward PLWHAs. This reinforces previous findings showing that educational efforts can challenge stereotypes and improve public perceptions.7479
The study’s findings align with broader research on HIV-related stigma and discrimination, emphasizing the importance of continuous efforts in community support, legislative reform, and education to address these issues. The regularity of stigma and discrimination reported by participants reflects the broader dynamics of HIV-related stigma. Family, friends, and healthcare providers were common sources of stigma, which can lead to feelings of guilt, rejection, and condemnation among PLWHAs. These experiences have a significant impact on their quality of life and mental health, underscoring the critical need to address stigma in HIV/AIDS care. 80,81
Interestingly, the study found a lower prevalence of overt discrimination and verbal abuse, which contrasts with some literature suggesting these forms of discrimination are more widespread. This discrepancy may stem from cultural differences in how stigma is perceived and expressed, as well as potential improvements in Ikeja’s efforts to reduce stigma. However, the mixed views on stigma indicate the complexity of HIV-related discrimination, highlighting the need for ongoing research and locally tailored solutions.83
A
A
A
The report provides valuable insights into the different dimensions of stigma faced by PLWHAs, as shown by the stigma subscales in Tables 4.5 and 4.6. These subscales—Personalized Stigma, Disclosure Concerns, Negative Self-Image, and Public Attitude—offer a comprehensive understanding of the stigma phenomenon and its impact on PLWHAs in Ikeja. This subscale measures internalized stigma, also known as self-stigma, which is the experience of feeling guilty, ashamed, or having a bad self-image due to one's HIV status. Studies on self-stigma in HIV-positive communities in Abeokuta, Nigeria; Tamil Nadu, India, confirms the idea that women may internalize negative societal attitudes more thoroughly than men, as seen by the somewhat higher ratings among females 36,59,85.
Perceptions of how the general public perceives and handles individuals living with HIV/AIDS are measured by this subscale. A strong conviction that the public has negative attitudes towards people living with HIV, which are a result of social prejudice and misinformation, is indicated by high scores on this subscale. Numerous studies support these conclusions, showing that stigma from the public still poses a serious obstacle to the quality of life for those living with HIV 56,86,87.
The findings from the subscale analysis are logical and align with current research on HIV stigma. Personalized Stigma, Disclosure Concerns, Negative Self-Image, and Public Attitude are all critical dimensions that impact the lives of individuals with HIV. These dimensions help to pinpoint areas where interventions can be most effective, such as public education to reduce societal stigma and supportive services to help individuals cope with internalized stigma. The gender differences observed, though not always statistically significant, highlight the need for gender-sensitive approaches in addressing HIV-related stigma. These insights are invaluable for developing comprehensive strategies to combat stigma and improve the well-being of people living with HIV/AIDS 88,89. The data showed that, in comparison to people under 20, those in the 20–29 and 30–39 age groups are substantially more likely to encounter stigma. This result is in line with the theory that widespread assumptions and misconceptions regarding the lifestyles of younger PLWHA contribute to their increased social stigma. Youth are sometimes unfairly condemned for imagined acts that may have contributed to their HIV status in many nations, including Nigeria. Cultural norms that stigmatize drug use and premarital sexual activity, both of which are frequently (and often incorrectly) linked to HIV transmission, may be the root cause of this age-related stigma 90.
Additionally, younger PLWHA may lack the social support systems that older individuals might have, exacerbating their vulnerability to stigma. The absence of strong family or community support can leave younger individuals feeling isolated and more susceptible to negative societal attitudes. This pattern aligns with previous research indicating that younger people with HIV face more pronounced stigma, making targeted interventions for this age group crucial.
Gender emerged as a key influence in discrimination but not in Stigma. It was discovered that the likelihood of discrimination was far lower for men than for women. This demonstrates the relationship between gender-based discrimination and HIV-related stigma. HIV-positive women frequently bear a dual burden: they are discriminated against because of their gender identity and stigmatized for having the virus 91,92.
Women may experience more severe societal repercussions and are frequently held responsible for HIV transmission within their families in many countries, including Nigeria. This social guilt can show up as a variety of discriminatory experiences, such as being neglected in medical settings or being shunned by the community. This research emphasizes how gender-sensitive strategies are necessary to combat HIV-related prejudice and make sure that women's particular needs are met.
Looking at different forms of stigmatization across gender distribution females living with HIV/AIDS in Ikeja experience slightly higher personalized stigma (mean score: 2.63) compared to males (2.29), though the difference is not statistically significant (P = 0.0946). This might be due to societal expectations placing more pressure on women. Disclosure concerns were nearly identical for both genders, suggesting a shared fear of stigma (P = 0.7391). Negative self-image scores were also similar, indicating internalized stigma affects both sexes equally (P = 0.1748).
A
Public attitude scores were high across the board, reflecting widespread societal stigma (P = 0.4760). These rational conclusions are consistent with recent research showing that stigma associated to HIV affects men and women in a similar way, highlighting the widespread nature of stigma irrespective of gender 93,94.
While marital status was not significantly associated with stigma or discrimination in this study, divorced individuals had higher, though not statistically significant, odds of experiencing both. This points to an intricate relationship in which other variables, such as social support and financial stability, interact with married status to predict stigma and discrimination rather than stigma or discrimination alone 9597. PLWHA who are divorced or alone may face more stigma and discrimination as a result of losing their spouse's support, which can be an important defense against negative societal perceptions. Furthermore, societal standards that stigmatize divorce or singlehood may make it harder for PLWHA to overcome these obstacles.
Religion and ethnicity were significant factors in stigma experiences. Those who identified as Hausa were much less likely than Yoruba people to face stigma. This might be explained by the different cultural perspectives that various ethnic groups have on HIV/AIDS. Communities that have more robust support networks within the community and less judgmental views towards disease, for instance, may create more conducive circumstances where stigma is less common.
Religion, although not significantly associated with stigma or discrimination in this study, still showed trends where individuals practicing Islam had higher odds of stigma. This finding suggests that religious beliefs and community practices might influence how HIV/AIDS is perceived and how individuals are treated. Previous studies have shown mixed results regarding the role of religion, indicating that it can either mitigate or exacerbate stigma depending on the religious context and its teachings about illness and morality 76,77,98.
Higher educational attainment was significantly associated with lower odds of experiencing discrimination. This suggests that education can serve as a protective factor, possibly because educated individuals are better equipped to understand HIV/AIDS, advocate for their rights, and navigate healthcare systems. Education might also foster more progressive attitudes towards HIV, reducing the likelihood of discriminatory behavior from others.
This is consistent with the larger body of literature that emphasizes the value of education in empowering people and lowering stigma and discrimination associated with health issues. Additionally, those with higher levels of education might have easier access to social networks and resources that help lessen the negative effects of discrimination 34,99.
Experiences of prejudice were strongly influenced by occupation, with artisans experiencing much greater odds than civil servants. This draws attention to the occupational vulnerabilities that some occupations have, especially those that are less stable and have a lower social status, which might make people more vulnerable to discrimination. Workplaces with pervasive prejudice toward HIV/AIDS or without policies protecting PLWHA can provide as fertile grounds for discrimination. This research highlights the significance of workplace interventions and regulations that safeguard the dignity and rights of PLWHA, guaranteeing equitable support for all occupational groups 71, 76, 100.
Both stigma and discrimination were influenced by geographic location. Outside of Ikeja, people were more likely to face stigma than outside of Lagos State, where prejudice was less likely to occur. This regional discrepancy may result from differing HIV/AIDS knowledge, resources, and support networks in various areas. It's possible that urban regions like Ikeja have stronger support networks and healthcare infrastructures, which lessen discrimination. On the other hand, stigma associated with HIV/AIDS may be higher in rural or less urbanized areas due to stronger traditional beliefs and limited access to factual information 101, 102.
Disclosure
of HIV status was substantially linked to increased risk of stigma. This research emphasizes the two-edged sword of disclosure: although it is necessary to obtain assistance and medical care, it can also subject people to stigma from society. People frequently avoid declaring their status out of fear of stigma, which can make it more difficult for them to get the support and treatment they need 56,103. This conclusion supports the necessity for safe disclosure contexts that shield people from stigma. Previous research has shown that disclosure can have detrimental societal implications.
The likelihood of facing stigma and discrimination was much decreased if one's partner's HIV status was unknown or negative. This implies that the social dynamics and support networks accessible to PLWHA can be impacted by the partner's status. Partners who do not know their status or who are HIV-negative may offer stronger support, lessening the negative effects of discrimination and stigma in society. The suffering of having been infected by a positive spouse may, despite the appearance of normalcy, intensify discrimination and stigma amongst Sero concordant couples 104,105.
There was a strong association found between higher income and a decreased likelihood of discrimination and stigma. This emphasizes how stable economies provide protection against stigma and discrimination, since those with higher wages may have better access to healthcare, social services, and educational opportunities. In line with the larger body of research on the protective benefits of socioeconomic position, economic empowerment can give PLWHA the means to stand up for their rights, get better healthcare, and create supportive social networks 106,107
CONCLUSION
The study concludes that stigma and prejudice against PLWHAs are still pervasive in Ikeja and have an impact on their general well-being, social inclusion, and access to healthcare. The difficulties that PLWHAs confront are mostly caused by socioeconomic issues, stigmas associated with culture and religion, and unfavorable attitudes from healthcare professionals. Even though stigma-related problems are becoming more widely recognized, there is still a significant need for improved education and focused treatments to deal with these problems. The results are consistent with previous research, which emphasizes the necessity for a multifaceted strategy to counteract stigma and discrimination connected to HIV.
List of abbreviation
AIDS Acquired immune deficiency syndrome
ART Anti-Retroviral Therapy
ATC Antiretroviral Therapy Centre
HAART Highly Active Anti-Retroviral Therapy
HIV Human immunodeficiency virus
NARHS National AIDS and Reproductive Health Survey
PEPFAR US President’s Emergency Plan for AIDS Relief
PLHIV People Living with HIV
PLWHA People Living With HIV/AIDS
PMTCT Prevention of Mother to Child Transmission
Declarations
Ethical Approval and Consent to participate:
A
ethical approval was obtained from the health research and ethics committee Lagos state university teaching hospital (LASUTH)
Consent for publication:
A
All authors agreed to publish this article
Competing interests:
The authors declare that they have no competing interests
A
Funding:
No funding was received for this study
A
Author Contribution
GSA conceptualised the study; all authors were involved in the literature review; AOO analysed the data from the field; All authors wrote the final and first drafts. All authors read and approved the final manuscript.
REFERENCES
1.
UNAID. UNAID Global AIDS update 2022. 2022;1–376. Available from: https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update_en.pdf
2.
Bin Ibrahim MA, Ho LP. From Acute Infection to Chronic Health Condition: The Role of the Social Sciences on the HIV/AIDS Global Epidemic. In: Handbook of Social Sciences and Global Public Health. Springer; 2023. p. 1–22.
3.
Fassinou LC, Hien H, Yombi JC, Nagot N, Kirakoya-Samadoulougou F. Availability and readiness of the health facilities to provide HIV counseling and testing and prevention of mother-to-child transmission services in Burkina Faso: a trend analysis from 2012 to 2018. BMC Health Serv Res. 2023;23(1):757.
4.
Balasubramaniam M, Pandhare J, Dash C. Immune control of HIV. J life Sci (Westlake Village, Calif). 2019;1(1):4.
5.
Tumwebaze M, Rubaihayo J, Harold M. Appraisal of existing HIV/AIDS prevention and control measures and presentation of innovative strategies to end HIV/AIDs epidemic by 2030. Open J Epidemiol. 2023;13(3):178–94.
6.
Assefa Y, Hill PS, Van Damme W, Dean J, Gilks CF. Leaving no one behind: Lessons from implementation of policies for universal HIV treatment to universal health coverage. Global Health [Internet]. 2020 Feb 24 [cited 2024 Jan 22];16(1):1–9. Available from: https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992-020-00549-4
7.
Cueto M, Lopes G. AIDS, Antiretrovirals, Brazil and the International Politics of Global Health, 1996–2008. Soc Hist Med [Internet]. 2021 Apr 7 [cited 2024 Jan 22];34(1):1–22. Available from: https://dx.doi.org/10.1093/shm/hkz044
8.
Olakunde BO, Adeyinka DA, Olawepo JO, Pharr JR, Ozigbu CE, Wakdok S, et al. Towards the elimination of mother-to-child transmission of HIV in Nigeria: a health system perspective of the achievements and challenges. Int Health. 2019;11(4):240–9.
9.
Bassey AE, Miteu D. A review of current trends in HIV epidemiology, surveillance, and control in Nigeria [Internet]. 2023 [cited 2024 Jan 22]. Available from: http://dx.doi.org/10.1097/MS9.0000000000000604
10.
Fernández-Luis S, Fuente-Soro L, Nhampossa T, Lopez-Varela E, Augusto O, Nhacolo A, et al. Prompt HIV diagnosis and antiretroviral treatment in postpartum women is crucial for prevention of mother to child transmission during breastfeeding: Survey results in a high HIV prevalence community in southern Mozambique after the implementation of Opti. PLoS One. 2022;17(8 August):1–18.
11.
Hospital HT. Social Support and Adherence To Anti-Retroviral Therapy Among Hiv Patients in University of Port- By Mbbs (Benin), Fwacp Matric No: 180464 a Dissertation in the Department of Epidemiology and Medical Statistics Submitted To the Faculty of Public Health. 2016;(November).
12.
Sahoo SS, Khanna P, Verma R, Verma M, Mahapatra S, Parija PP, et al. Social stigma and its determinants among people living with HIV / AIDS: A cross – sectional study at ART center in North India. 2020;
13.
NACA. Stigma and Discrimination Reduction in the National HIV/AIDS Response [Internet]. 2016. 43 p. Available from: http://naca.gov.ng/national-hivaids-stigma-reduction-strategy-2/
14.
Tolu G, Id F, Lockwood C, Woldie M, Munn Z. Reducing HIV-related stigma and discrimination in healthcare settings: A systematic review of quantitative evidence. 2019;1–23.
15.
Monjok E, Smesny A, Essien EJ. HIV/AIDS-related stigma and discrimination in Nigeria: review of research studies and future directions for prevention strategies. Afr J Reprod Health. 2009;13(3):21–35.
16.
Stringer KL, Mukherjee T, McCrimmon T, Terlikbayeva A, Primbetovac S, Darisheva M, et al. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan. Int J Drug Policy. 2019;68:27–36.
17.
Abrams JA, Odlum M, Tillett E, Haley D, Justman J, Hodder S, et al. Strategies for increasing impact, engagement, and accessibility in HIV prevention programs: suggestions from women in urban high HIV burden counties in the Eastern United States (HPTN 064). BMC Public Health. 2020;20:1–16.
18.
Martin MO, von Davier M, Mullis IVS. Methods and procedures: TIMSS 2019 Technical Report. Int Assoc Eval Educ Achiev. 2020;
19.
Survey I. TECHNICAL REPORT. 2018; WHO
20.
Assefa Y, Gilks CF. Ending the epidemic of HIV/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries? Int J Infect Dis. 2020;100:273–7.
A
21.
He N. Research progress in the epidemiology of HIV/AIDS in China. China CDC Wkly. 2021;3(48):1022.
22.
Gao Y, Kraft JC, Yu D, Ho RJY. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy. Eur J Pharm Biopharm. 2019;138:75–91.
23.
Kumar A, Mahajan A, Salazar EA, Pruitt K, Guzman CA, Clauss MA, et al. Impact of human immunodeficiency virus on pulmonary vascular disease. Glob Cardiol Sci Pract. 2021;2021(2).
24.
Valenzuela-Oré F, Angulo-Bazán Y, Lazóriga-Sandoval LD, Cruz-Vilcarromero NL, Cubas-Sagardia CR. Factors influencing adherence to anti-retroviral therapy in amazonian indigenous people living with HIV/AIDS. BMC Public Health. 2023;23(1):1–10.
25.
Uwakwe FC, Aloh JN. Cultural practices and human rights implications on HIV/AIDS discrimination and other related issues in Nigeria. Nnamdi Azikiwe Univ J Int Law Jurisprud. 2019;10(1):20–31.
26.
Hamid AM, Sule GM. Media Campaign Exposure and HIV/AIDS Prevention: 1980–2020. In: AIDS Updates-Recent Advances and New Perspectives. IntechOpen; 2021.
27.
Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci. 2018;25(4):697–703.
28.
Yen YF, Chen M, Jen IA, Chuang PH, Lee CY, Lin SI, et al. Short-and long-term risks of highly active antiretroviral treatment with incident opportunistic infections among people living with HIV/AIDS. Sci Rep. 2019;9(1):3476.
29.
Tewachew AS, Mekonnen WN, Mekuria AD, Amare YE. Determinants of opportunistic infections among hiv-positive patients on haart in debre berhan referral hospital, north shoa zone, ethiopia, 2020: A case–control study. HIV/AIDS-Research Palliat Care. 2021;337–47.
30.
Dereje N, Moges K, Nigatu Y, Holland R. Prevalence And predictors of opportunistic infections among HIV positive adults on antiretroviral therapy (On-ART) versus Pre-ART In Addis Ababa, Ethiopia: A comparative cross-sectional study. HIV/AIDS-Research Palliat Care. 2019;229–37.
A
31.
Isika AI, Shehu A, Dahiru T, Obi IF, Oku AO, Balogun MS, et al. Factors influencing adherence to antiretroviral therapy among HIV-infected adults in Cross River State, Nigeria: a cross-sectional study. Pan Afr Med J. 2022;43.
A
32.
Umeokonkwo CD, Onoka CA, Agu PA, Ossai EN, Balogun MS, Ogbonnaya LU. Retention in care and adherence to HIV and AIDS treatment in Anambra State Nigeria. BMC Infect Dis. 2019;19:1–11.
33.
Agu IC, Mbachu CO, Okeke C, Eze I, Agu C, Ezenwaka U, et al. Misconceptions about transmission, symptoms and prevention of HIV/AIDS among adolescents in Ebonyi state, South-east Nigeria. BMC Res Notes. 2020;13:1–5.
34.
Adimora DE, Aye EN, Akaneme IN, Nwokenna EN, Akubuilo FE. Stigmatization and discrimination as predictors of self-esteem of people living with HIV and AIDS in Nigeria. Afr Health Sci. 2019;19(4):3160–71.
35.
Wilandika A, Yusuf A. The Driving Factors of Social Stigma Against People With HIV/AIDS: An Integrative Review. Malaysian J Med Heal Sci. 2023;19.
36.
Bwosh SD. HIV and AIDS and the stigmatisation of woman by men in Nigeria: a pastoral care intervention strategy. Stellenbosch: Stellenbosch University; 2022.
A
37.
Ismail N, Matillya N, Ratansi R, Mbekenga C. Barriers to timely disclosure of HIV serostatus: A qualitative study at care and treatment centers in Dar es Salaam, Tanzania. PLoS One. 2021;16(8):e0256537.
A
38.
Obeagu EI, Obeagu GU. Unmasking the Truth: Addressing Stigma in the Fight Against HIV. Elit J Public Heal. 2024;2(1):8–22.
A
39.
Ingabire C, Watnick D, Gasana J, Umwiza F, Munyaneza A, Kubwimana G, et al. Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative study. BMC Public Health. 2023;23(1):1817.
40.
Chejana NJ. Barriers to Adherence to Antiretroviral Medication Among Patients with High Viral Load Compared to Low Viral Load, Mokhotlong, Lesotho. University of Johannesburg (South Africa); 2021.
A
41.
Birdthistle I, Tanton C, Tomita A, de Graaf K, Schaffnit SB, Tanser F, et al. Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis. Lancet Glob Heal. 2019;7(11):e1521–40.
A
42.
Bakeera-Kitaka S. Exploring the health and wellbeing of adolescents living with HIV as they grow into adulthood: unique challenges in a low resource setting. University of Antwerp; 2020.
A
43.
Williams CKO, Williams CKO. Global HIV/AIDS burden and associated diseases. Cancer AIDS Part II Cancer Pathog Epidemiol. 2019;59–96.
A
44.
Ibrahim SA, Sabitu K, Abubakar A, Poggensee G, Ibrahim S, Riyad M, et al. Demographic factors associated with HIV infection between low and high prevalence areas in Nigeria, 2015. Pan Afr Med J. 2019;32(Suppl 1).
A
45.
Tlou B. The influence of marital status on HIV infection in an HIV hyperendemic area of rural South Africa, 2000–2017. African J AIDS Res. 2019;18(1):65–71.
A
46.
Nabukenya AM, Nambuusi A, Matovu JKB. Risk factors for HIV infection among married couples in Rakai, Uganda: a cross-sectional study. BMC Infect Dis. 2020;20(1):1–8.
A
47.
Wouk J, Rechenchoski DZ, Rodrigues BCD, Ribelato EV, Faccin-Galhardi LC. Viral infections and their relationship to neurological disorders. Arch Virol. 2021;166:733–53.
A
48.
Obengo TJ. A utilitarian assessment of the relevance of genetic therapies for HIV-AIDS in Africa, with special reference to the situation in Kenya. Stellenbosch: Stellenbosch University.; 2020.
A
49.
Oladele DA, Idigbe IE, Ekama SO, Gbajabiamila T, Ohihoin AG, David AN, et al. “Their place is beyond the town’s border”: A qualitative exploration of stigma associated with tuberculosis in rural and urban areas of Lagos, Nigeria. Health Soc Care Community. 2021;29(6):1789–98.
A
50.
van Veelen R, Veldman J, Van Laar C, Derks B. Distancing from a stigmatized social identity: State of the art and future research agenda on self-group distancing. Eur J Soc Psychol. 2020;50(6):1089–107.
A
51.
Meadows A, Higgs S. Challenging oppression: A social identity model of stigma resistance in higher-weight individuals. Body Image. 2022;42:237–45.
A
52.
Data.FI. Mind the Gap: Leveraging the National HIV/AIDS Indicator and Impact Survey (NAIIS) Data to Identify Service Delivery Gaps in Akwa Ibom State. DataFi Niger Inf Prod. 2020;(August).
A
53.
Ogunyemi AO, Adubiaro FM, Oluwole EO, Somefun EO, Olubodun T. Stigma, discrimination and non-disclosure among young people living with HIV in Lagos, Nigeria. Pan Afr Med J. 2022;41.
A
54.
Dos Santos MML, Kruger P, Mellors SE, Wolvaardt G, Van Der Ryst E. An exploratory survey measuring stigma and discrimination experienced by people living with HIV/AIDS in South Africa: the People Living with HIV Stigma Index. BMC Public Health. 2014;14:1–13.
A
55.
Teshale AB, Tesema GA. Discriminatory attitude towards people living with HIV/AIDS and its associated factors among adult population in 15 sub-Saharan African nations. PLoS One. 2022;17(2):e0261978.
56.
Oduenyi C, Ugwa E, Ojukwu Z, Ojukwu-Ajasigwe J. An exploratory study of stigma and discrimination among people living with HIV/AIDS in Abuja municipal area council, Nigeria. Afr J Reprod Health. 2019;23(1):88–99.
57.
Arisegi SA, Tomori BA. Attitudes and practices related to stigma and discrimination against persons living with HIV/AIDS among health workers in a tertiary care facility in Sokoto, Nigeria. Int Arch Med Med Sci. 2019;1(1).
A
58.
June A, Quarter E. Hiv/aidsepidemiccontrol. 2023;(June):1–8.
59.
Oke OO, Akinboro AO, Olanrewaju FO, Oke OA, Omololu AS. Assessment of HIV-related stigma and determinants among people living with HIV/AIDS in Abeokuta, Nigeria: A cross-sectional study. SAGE open Med. 2019;7:2050312119869109.
60.
Discrimination and Other Related Issues in Nigeria. 2011;29:20–31.
61.
National Bureau of Statistics. Demographic Statistics Bulletin 2020. Natl Bur Stat. 2020;(May):1–26.
62.
Letshwenyo-Maruatona SB, Madisa M, Boitshwarelo T, George-Kefilwe B, Kingori C, Ice G, et al. Association between HIV/AIDS knowledge and stigma towards people living with HIV/AIDS in Botswana. African J AIDS Res. 2019;18(1):58–64.
63.
Shah S, Elgalib A, Al-Wahaibi A, Al-Fori M, Raju P, Al-Skaiti M, et al. Knowledge, attitudes and practices related to HIV stigma and discrimination among healthcare workers in Oman. Sultan Qaboos Univ Med J. 2020;20(1):e29.
64.
Alwafi HA, Meer AMT, Shabkah A, Mehdawi FS, El-Haddad H, Bahabri N, et al. Knowledge and attitudes toward HIV/AIDS among the general population of Jeddah, Saudi Arabia. J Infect Public Health. 2018;11(1):80–4.
65.
Sallam M, Alabbadi AM, Abdel-Razeq S, Battah K, Malkawi L, Al-Abbadi MA, et al. HIV knowledge and stigmatizing attitude towards people living with HIV/AIDS among medical students in Jordan. Int J Environ Res Public Health. 2022;19(2):745.
66.
Ferguson L, Gruskin S, Bolshakova M, Yagyu S, Fu N, Cabrera N, et al. Frameworks and measures for HIV-related internalized stigma, stigma and discrimination in healthcare and in laws and policies: a systematic review. J Int AIDS Soc. 2022;25:e25915.
67.
Thar PP. Factors association of discriminatory attitudes toward people living with HIV/AIDS among adult citizens in Myanmar: an analysis of 2015–2016 Myanmar demographic and health survey. 2022;
68.
Ehiri JE, Alaofè HS, Yesufu V, Balogun M, Iwelunmor J, Kram NAZ, et al. AIDS-related stigmatisation in the healthcare setting: a study of primary healthcare centres that provide services for prevention of mother-to-child transmission of HIV in Lagos, Nigeria. BMJ Open. 2019;9(5):e026322.
69.
Kabbash IA, Abo Ali EA, Elgendy MM, Abdrabo MM, Salem HM, Gouda MR, et al. HIV/AIDS-related stigma and discrimination among health care workers at Tanta University Hospitals, Egypt. Environ Sci Pollut Res. 2018;25:30755–62.
70.
Fauk NK, Ward PR, Hawke K, Mwanri L. HIV stigma and discrimination: perspectives and personal experiences of healthcare providers in Yogyakarta and Belu, Indonesia. Front Med. 2021;8:625787.
71.
Ofili MA. A mediation model analyses of employment discrimination against people living with HIV/AIDS in south western Nigeria. North-West University (South-Africa); 2019.
A
72.
Lightner JS, Rajabiun S, Cabral HJ, Flaherty J, Shank J, Brooks R. Associations of internalized and anticipated HIV stigma with returning to work for persons living with HIV. PLoS One. 2021;16(6):e0252783.
73.
Robinson P, Turk D, Jilka S, Cella M. Measuring attitudes towards mental health using social media: investigating stigma and trivialisation. Soc Psychiatry Psychiatr Epidemiol. 2019;54:51–8.
74.
Obeagu EI, Igwe MC, Obeagu GU. The Power of Unity: Collective Efforts in Confronting HIV Stigma. Elit J Public Heal. 2024;2(3):22–36.
75.
Nalah AB, Azlinda A, Paramjit SJS. Harmful cultural practices and HIV stigma as psychosocial issues in North Central Nigeria. Int J Hum Rights Healthc. 2021;14(2):104–16.
76.
Odimegwu CO, Alabi O, De Wet N, Akinyemi JO. Ethnic heterogeneity in the determinants of HIV/AIDS stigma and discrimination among Nigeria women. BMC Public Health. 2018;18:1–12.
77.
Reyes-Estrada M, Varas-Díaz N, Parker R, Padilla M, Rodríguez-Madera S. Religion and HIV-related stigma among nurses who work with people living with HIV/AIDS in Puerto Rico. J Int Assoc Provid AIDS Care. 2018;17:2325958218773365.
78.
Otieno PM. Cultural beliefs and disclosure among People Living With HIV&AIDS (PLWHAs) in Msambweni County Referral Hospital, Kwale County, Kenya. development. 2024;19:4.
79.
Nyblade L, Srinivasan K, Mazur A, Raj T, Patil DS, Devadass D, et al. HIV stigma reduction for health facility staff: development of a blended-learning intervention. Front public Heal. 2018;6:362233.
80.
Chime OH, Arinze-Onyia SU, Ossai EN. Examining the effect of peer-support on self-stigma among persons living with HIV/AIDS. Pan Afr Med J. 2019;34(1).
81.
Mumin AA, Gyasi RM, Segbefia AY, Forkuor D, Ganle JK. Internalised and social experiences of HIV-induced stigma and discrimination in urban Ghana. Glob Soc Welf. 2018;5:83–93.
A
82.
Demirel OF, Mayda PY, Yıldız N, Sağlam H, Koçak BT, Habip Z, et al. Self-stigma, depression, and anxiety levels of people living with HIV in Turkey. Eur J Psychiatry. 2018;32(4):182–6.
83.
Krüsi A, Ranville F, Gurney L, Lyons T, Shoveller J, Shannon K. Positive sexuality: HIV disclosure, gender, violence and the law—A qualitative study. PLoS One. 2018;13(8):e0202776.
A
84.
Dessalegn NG, Hailemichael RG, Shewa-Amare A, Sawleshwarkar S, Lodebo B, Amberbir A, et al. HIV Disclosure: HIV-positive status disclosure to sexual partners among individuals receiving HIV care in Addis Ababa, Ethiopia. PLoS One. 2019;14(2):e0211967.
85.
Mercy SGS. An intervention program to combat internalized stigma among people living with HIV/AIDS in Chennai city of Tamil Nadu, India. 2018.
86.
Chime PE, Okoli PC, Chime EN, Anekpo CC, Ozougwu AO, Ofojebe PC. Diseases associated with stigma: A review. Open J Psychiatry. 2022;12(2):129–40.
87.
Legesse Tesemma A, Girma Abate M, Hailemariam Abebo Z, Estifanos Madebo W. Determinants of poor quality of life among adults living with HIV and enrolled in highly active anti-retroviral therapy at public health facilities of Arba Minch Town Administration in Southern Ethiopia. HIV/AIDS-Research Palliat Care. 2019;387–94.
88.
Van Der Kooij YL, Kupková A, Den Daas C, Van Den Berk GEL, Kleene MJT, Jansen HSE, et al. Role of self-stigma in pathways from HIV-related stigma to quality of life among people living with HIV. AIDS Patient Care STDS. 2021;35(6):231–8.
89.
Williams R, Cook R, Brumback B, Cook C, Ezenwa M, Spencer E, et al. The relationship between individual characteristics and HIV-related stigma in adults living with HIV: medical monitoring project, Florida, 2015–2016. BMC Public Health. 2020;20:1–10.
90.
Sahoo SS, Khanna P, Verma R, Verma M, Mahapatra S, Parija PP, et al. Social stigma and its determinants among people living with HIV/AIDS: A cross-sectional study at ART center in North India. J Fam Med Prim Care. 2020;9(11):5646.
91.
Magno L, Silva LAV da, Veras MA, Pereira-Santos M, Dourado I. Stigma and discrimination related to gender identity and vulnerability to HIV/AIDS among transgender women: a systematic review. Cad Saude Publica. 2019;35.
92.
Logie CH, Earnshaw V, Ahmed R, Rowe SE, Fagan A, Argyropoulos A, et al. Experiences of gender-based stigma and health care-related outcomes in the African region: A scoping review. Stigma Heal. 2024;
93.
Yaya S, Ghose B, Udenigwe O, Shah V, Hudani A, Ekholuenetale M. Knowledge and attitude of HIV/AIDS among women in Nigeria: a cross-sectional study. Eur J Public Health. 2019;29(1):111–7.
94.
Augustine Bala N, Azman A, Singh PSJ. The impact of gender discrimination and HIV stigma on women living in North Central Nigeria. Cogent Soc Sci. 2022;8(1):2027612.
95.
Ngige LW, Ndayala PD. Effects of Anticipated Stigma and Discrimination on Self-Disclosure of HIV Seropositive Status among People Living with HIV and AIDS in Kenya. East African J Heal Sci. 2020;2(1):51–61.
96.
Mehta KG, Baxi R, Patel S, Chavda P, Mazumdar V. Stigma, discrimination, and domestic violence experienced by women living with HIV: a cross-sectional study from western India. Indian J community Med. 2019;44(4):373–7.
97.
Kaur D. Challenges in the lives of HIV positive women. Int J Multidiscip Res. 2020;6(6):103–9.
98.
Adekoya P, Lannap FD, Ajonye FA, Amadiegwu S, Okereke I, Elochukwu C, et al. Experiences of Stigmatization and Discrimination in Accessing Health Care Services Among People Living with HIV (PLHIV) in Akwa Ibom State, Nigeria. HIV/AIDS-Research Palliat Care. 2024;45–58.
99.
Dewi DMSK, Sari JDE, Fatah MZ, Astutik E. Stigma and discrimination against people living with HIV and AIDS in Banyuwangi, East Java, Indonesia. In: 4th International Symposium on Health Research (ISHR 2019). Atlantis Press; 2020. p. 154–9.
A
100.
Dong X, Yang J, Peng L, Pang M, Zhang J, Zhang Z, et al. HIV-related stigma and discrimination amongst healthcare providers in Guangzhou, China. BMC Public Health. 2018;18:1–10.
A
101.
Oladele DA, Balogun MR, Odeyemi K, Salako BL. A Comparative Study of Knowledge, Attitude, and Determinants of Tuberculosis-Associated Stigma in Rural and Urban Communities of Lagos State, Nigeria. Tuberc Res Treat. 2020;2020(1):1964759.
A
102.
Ashaba S, Cooper-Vince CE, Vořechovská D, Rukundo GZ, Maling S, Akena D, et al. Community beliefs, HIV stigma, and depression among adolescents living with HIV in rural Uganda. African J AIDS Res. 2019;18(3):169–80.
103.
Adam A, Fusheini A, Ayanore MA, Amuna N, Agbozo F, Kugbey N, et al. HIV stigma and status disclosure in three municipalities in Ghana. Ann Glob Heal. 2021;87(1).
104.
Sowell RL. Stigma and discrimination: threats to living positively with human immunodeficiency virus. Nurs Clin. 2018;53(1):111–21.
105.
Spangler SA, Abuogi LL, Akama E, Bukusi EA, Helova A, Musoke P, et al. From ‘half-dead’to being ‘free’: resistance to HIV stigma, self-disclosure and support for PMTCT/HIV care among couples living with HIV in Kenya. Cult Health Sex. 2018;20(5):489–503.
106.
Oturu K, O’Brien O, Ozo-Eson PI. Barriers and enabling structural forces affecting access to antiretroviral therapy in Nigeria. BMC Public Health. 2024;24(1):105.
107.
EDUN MBB. Of Sustainability and HIV Program in Nigeria. 2021;
APPENDIX
APPENDIX I
Consent Form for Research
Title of Research Project
Stigma, Discrimination and Associated Determinants Among People Living With HIV/Aids Accessing Anti-Retroviral Therapy in Ikeja Lagos State Nigeria.
Principal Investigator
Gambo Sidi Ali
What you should know about this study
You are being asked to join a research study
This consent form explains the research study and your part in the study
Please ask questions at any time about anything you do not understand
Ask any member of the study team to explain any words or information in this informed consent
that you do not understand
Purpose of Research Project:
This study aims to comprehensively explore the knowledge, prevalence, types and determinants of stigma and discrimination among people accessing Anti-retroviral Therapy (ART) in Ikeja, Lagos State, Nigeria.
Procedures:
You are required to answer some questions on the above-stated topic. This should take about
15–20 minutes of your time. Please try to be sincere brief and clear as possible in your
contributions.
Risk/Discomfort:
You may feel uncomfortable with divulging personal information or expressing your feelings on
A
the certain aspects of your life and health status. There will be no needle pricks or bloodletting
for any tests to be done.
Anticipated Benefits:
Your participation in this study will significantly improve the knowledge base on the level of
Stigma and discrimination experienced by HIV patients and its association with access to ART service.
This may serve as baseline reference for policy formulation, program planning, implementation, and evaluation towards improving anti-retroviral therapy among HIV patients in
Lagos state and in Nigeria.
Voluntary Participation:
You are a volunteer. You have the right to change your mind, or decide not to participate at any
point during the study. There are no penalty or loss of benefit if you decide to quit
the study. You should ask the research assistant or principal investigator any question you may
have about this research study. During the study, we will tell you if we learn any new
information that might affect whether you wish to continue to be in the study.
Who do I call if I have questions or problems?
Call the Principal investigator (Mr. Gambo Sidi Ali), at 08052257611
What does your signature on this consent form mean?
Your signature on this form means:
You have been informed about this study’s purpose, procedures, possible benefits, and risks
You have received a copy of this consent
You have been given the chance to ask question before you sign
You have been told that you can ask any question at any time
You have voluntarily agreed to be in this study
You are free to stop being in this study at any time
If you stop being in this study, you understand it will not in any way affect your treatment at the
ART Clinic.
You have agreed to co-operate with Mr. Gambo Sidi Ali and the research staff and to tell
them immediately if you experience any unexpected or unusual symptoms.
Please indicate your name (participant):
Signature or Mark of Participant:
Date:
Signature of Person obtaining consent: Date:
Witness to consent if participant is unable to read or write Date
Signed Copies of this consent form must be:
Retained on a file by the principal investigator
Given to the subject. This consent document is NOT valid without the Ethical Committee stamp
of approval.
APPENDIX II
QUESTIONNAIRE
AHMADU BELLO UNIVERSITY, ZARIA, KADUNA STATE, NIGERIA.
DEPARTMENT OF PUBLIC HEALTH
QUESTIONNAIRE ON THE STIGMA & DISCRIMINATION, AND ASSOCIATED DETERMINANTS AMONG PEOPLE LIVING WITH HIV/AIDS ACCESSING ANTI-RETROVIRAL THERAPY IN IKEJA LOCAL GOVERNMENT AREA, LAGOS STATE NIGERIA
Dear respondent,
The attached interview guide is intended to elicit information on the above topic as a postgraduate student of the above-named Department and University. The study aims to identify determinants of stigma & discrimination among people living with HIV/AIDS(PLWHAs). Kindly note that your participation is voluntary and obtained information will not be used for reasons other than the purpose of this study.
We kindly request your cooperation and active participation to design training programs that will enhance knowledge and improve the quality of healthcare services.
Date: ………………………………. Study ID number ………
Instruction
Kindly respond to the below questions as sincere as possible in the provided spaces by ticking (√).
Socio-demographic
Age as at last Birthday: ……………..yrs.
Gender: a) Male ( ) b) Female ( )
Marital Status: a) Single ( ) b) Married ( ) c) Divorced ( ) d) Separated ( )
Partner’s HIV Status ( )a) Positive ( ) b) Negative ( ) c) Unknown ( ) d) Not Applicable ( )
Ethnicity: a) Yoruba ( ) b) Igbo ( ) c) Hausa ( ) c) others (specify)………………………..
Religion: a) Christianity ( ) b) Islam ( ) c) Traditional ( ) d) Others (specify)………………
Occupation: (a) unemployed ( ) (b) self-employed ( ) (c) Civil Servant ( ) (d) Artificer ( ) (e) Others(specify)…………
Socioeconomic status
Monthly Income: please specify…………..
Educational level: a) None ( ) b) Primary ( ) c) Secondary ( ) d) Tertiary ( )
Current Employment Status: a) Employed ( ) b) Unemployed ( )
Type of Employment: a) Government ( ) b) Private Self ( ) c) Private non-Self
Number of Dependents: Please Specify………..
Residence: a) Within the LGA ( ) b) Outside the LGA ( ) c) Outside the State
How long have you been on ART: Please Specify……….
Knowledge:
Are you aware of what stigma related to HIV/AIDS means?a) Yes ( ) b) No ()
Have you received information regarding discrimination against PLWHAs in Ikeja?
a) Yes ( ) b) No ( ) Do you know about support services available to address stigma and discrimination faced by PLWHAs?a) Yes ( ) b) No ( )
Have you participated in educational programs related to HIV/AIDS stigma and discrimination?a) Yes ( ) b) No ( )
Are you aware that reducing stigma could improve healthcare access for PLWHAs?
a) Yes ( ) b) No ( )
Prevalence:
Have you ever been treated differently by healthcare providers due to your HIV status?
a) Yes ( ) b) No ( ) Have you encountered negative attitudes or behaviors from family or friends because of your HIV status?a) Yes ( ) b) No ( )
Have you ever felt ashamed or judged because of your HIV status?a) Yes ( ) b) No ( )
Do you believe there is widespread discrimination against PLWHAs in Ikeja?a) Yes ( ) b) No ( )
Have you personally experienced verbal abuse or insults related to your HIV status?
a) Yes ( ) b) No ( )
Types and Sources of Stigma/Discrimination:
Have you experienced stigma while accessing healthcare services for HIV/AIDS?a) Yes ( ) b) No ( )
Have you encountered discrimination in educational or workplace settings due to your HIV status?a) Yes ( ) b) No ( )
Do you perceive media or societal attitudes contribute to stigma associated with HIV/AIDS?
a.
a) Yes ( ) b) No ( )How do religious or cultural beliefs influence the treatment of PLWHAs in your community?
b.
a) Good ( ) b) Poor ( )Have you witnessed instances where PLWHAs were excluded from community events due to stigma?
c.
a) Yes ( ) b) No ( )
Determinants Assessment:Do you believe poverty or socioeconomic status influences how PLWHAs are treated in Ikeja?a) Yes ( ) b) No ( )
Have you experienced stigma or discrimination due to gender or sexual orientation along with your HIV status?a) Yes ( ) b) No ( )
Do healthcare provider attitudes affect stigma faced by PLWHAs?a) Yes ( ) b) No ( )
Do you think education level or awareness impacts how people treat PLWHAs in Ikeja?a) Yes ( ) b) No ( )
Are political or governmental policies contributing to discrimination against PLWHAs?
a) Yes ( ) b) No ( )
Factors affecting Stigma and Discrimination
Do you perceive the community in Ikeja to hold negative attitudes towards PLWHAs?a) Yes ( ) b) No ( )
Have you observed community-based programs aimed at reducing stigma against PLWHAs in Ikeja?
a) Yes ( ) b) No ( )
Do you believe media representations of HIV/AIDS contribute to negative perceptions and stigma?a) Yes ( ) b) No ( )
Have you noticed media campaigns addressing HIV/AIDS stigma in Ikeja?
a) Yes ( ) b) No ( )Have you personally encountered healthcare providers displaying stigma towards PLWHAs?a) Yes ( ) b) No ( )
Do you think healthcare provider attitudes affect PLWHAs' willingness to seek healthcare services?a) Yes ( ) b) No ( )
Do PLWHAs in Ikeja face challenges accessing ART and necessary healthcare services due to stigma?a) Yes ( ) b) No ( )
Have you or others encountered barriers while accessing healthcare due to HIV/AIDS-related stigma?a) Yes ( ) b) No ( )
Individual and Psychological Factors:Disclosure of HIV Status:Are PLWHAs in Ikeja comfortable disclosing their HIV status to others?a) Yes ( ) b) No ( )
Does fear of stigma or discrimination influence the decision to disclose HIV status?a) Yes ( ) b) No ( )
Mental Health Impact:Have you observed changes in mental health or self-esteem among PLWHAs due to stigma?a) Yes ( ) b) No ( )
Do you believe stigma significantly affects the mental well-being and social interactions of PLWHAs?a) Yes ( ) b) No ( )
Socioeconomic Factors:Poverty and Stigma:Do you think poverty amplifies the stigma experienced by PLWHAs in Ikeja?a) Yes ( ) b) No ( )
Have you noticed differences in the treatment of PLWHAs based on socioeconomic status?
a) Yes ( ) b) No ( )Education and Awareness:Can education and awareness programs substantially reduce stigma and discrimination related to HIV/AIDS?a) Yes ( ) b) No ( )
Have educational campaigns in Ikeja shown any impact on reducing stigma against PLWHAs?
a) Yes ( ) b) No ( )
Have been gossiped about?
a)
Yes b) No c) Don’t know
Verbally insulted/harassed or threatened
a)
Yes b) No
Husband/spouse/other household member have been discriminated against?
a)
Yes b) No c) Don’t know
Sexual rejection?
a)
Yes b) No
Excluded from social gatherings?
a)
Yes b) No
Discriminated against by other PLWHAs?
a)
Yes b) No
Excluded from religious activities?
a)
Yes b) No
THANKS FOR YOUR PARTICIPATION.
Appendix III: Ethical Approval
Click here to Correct
Total words in MS: 8574
Total words in Title: 18
Total words in Abstract: 458
Total Keyword count: 3
Total Images in MS: 1
Total Tables in MS: 13
Total Reference count: 107